2nd Annual Cancer Genome Summit
Tuesday, December 4 – Thursday, December 6 2012
Location: Boston, MA
Optimizing drug development, furthering personalized medicine, improving patient outcomes
Gain exclusive information and expert insights from all cancer genome stakeholders in order to optimize drug development, further personalized medicine and improve patient outcomes.
The Cancer Genome Summit is the only meeting which brings together thought leaders from pharma, academia and the clinic to present the very latest clinical data. Sharing these insights holds the key to accessing the cancer genome. This year’s meeting will show you how to identify new drug targets, combat resistance mechanisms, streamline clinical trials and improve clinical management.
Imagine yourself in a room full with the leading pharma, biotech and academic organizations all speaking about how they are harnessing the cancer genome to revolutionize their drug development programs and patient treatment choice.
MassBio members are eligible for a 10% discount off the registration fee. Simply quote ‘MASSBIO’ when registering.